Biocoral, Inc. · Levallois-Perret France (OTC: BCRA)
| 38 Rue Anatole France | Phone: +33-1-47-57-98-43 |
| Levallois-Perret | Fax: +33-1-47-57-89-76 |
| 92594 | |
| France | 
Map This Company |
Biocoral, Inc. Rankings
Company Description
Biocoral heals human bones with marine-life skeletons. The biomaterials company develops bone-graft substitutes derived from natural coral. The company's chief product, Biocoral, consists primarily of calcium carbonate and is very similar to bone tissue. It is used primarily by surgeons and doctors to treat and prevent fractures resulting from osteoporosis. Biocoral is also used for additional orthopedic, facial reconstruction, and oral surgery applications. The company's products are sold in Europe and Asia through its Biocoral France division. Biocoral plans to seek FDA approval to sell its products in the US.
Biocoral, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - OTC: BCRA Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 9 |
Executives
3 executives listed for Biocoral, Inc.'s Levallois-Perret, France location.
| Chairman, President, and CEO | Nasser Nassiri | |
|---|---|---|
| Secretary, Treasurer, and Director | Yuhko Grossman | |
| Director | Jean Darondel |